Anti-apoptotic and Immunomodulatory Effect of CB2 Agonist, JWH133, in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy
Introduction: Neonatal HIE is associated with high morbidity and mortality. Current research, is focused on developing alternative treatments to therapeutic hypothermia for treatment of HIE. The endocannabinoid system is known to be influential in neuronal protection. Activation of brain CB2 recepto...
Saved in:
Main Authors: | Bhavna Gupta (Author), Mary G. Hornick (Author), Seema Briyal (Author), Ramona Donovan (Author), Preetha Prazad (Author), Anil Gulati (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
by: Hebaallah Mamdouh Hashiesh, et al.
Published: (2021) -
Exposure to Morphine and Caffeine Induces Apoptosis and Mitochondrial Dysfunction in a Neonatal Rat Brain
by: Sweatha Kasala, et al.
Published: (2020) -
Synthetic Cannabinoid Receptor Agonist 'JWH-018' does not mimic Serotonin
by: Adam Pottsa, et al.
Published: (2022) -
Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female Mice
by: Henry L. Blanton, et al.
Published: (2022) -
Neuroprotective Effect of IRL-1620, an Endothelin B Receptor Agonist, on a Pediatric Rat Model of Middle Cerebral Artery Occlusion
by: Enrique G. Cifuentes, et al.
Published: (2018)